Akili Inc (AKLI) Stock
AKLI is no longer traded. Akili was delisted from the Nasdaq in July 2024.
Prices on this page are historical; the last trade was July 1, 2024 at $0.43.
Akili stock price history
AKLI final trading statistics
- Final close
- $0.43
- Final trading day
- Jul 1, 2024
- Market cap at delisting
- $34.01M
- Shares outstanding
- 78.73M
- Final 52-week range
- $0.19 – $1.25
- Avg. volume (final 3 mo.)
- 1,984,250
- All-time high (split-adj.)
- $14.07 · Aug 2022
- All-time low (split-adj.)
- $0.21 · Apr 2024
- Return since IPO
- -95.7%
- Beta
- 1.73
- Book value / share
- $0.64
- Price / book
- 0.68
Akili annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $1.68M | -$59.5M | -$0.69 |
| FY2022 | $323.0K | -$8.0M | -$0.46 |
| FY2021 | $538.0K | -$61.8M | -$0.08 |
| FY2020 | $3.94M | -$25.6M | — |
| FY2019 | $19.99M | -$20.6M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Akili Inc
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts. As of July 1, 2024, Akili, Inc. operates as a subsidiary of Virtual Therapeutics Corp.
Akili stock FAQ
What happened to Akili stock?
Akili stock was delisted from the Nasdaq. Its final close was $0.43 on July 1, 2024.
Is AKLI stock still trading?
No. AKLI was delisted from the Nasdaq in July 2024 and no longer trades on a U.S. exchange.
What was the last price of AKLI stock?
AKLI closed at $0.43 on its final trading day, July 1, 2024, for a market value of about $34.01M.
What were Akili's revenue and earnings in its last full fiscal year?
Akili reported revenue of $1.68M and net income of -$59.5M in fiscal 2023, its last full year as a public company.
When did Akili go public?
Akili Inc stock began trading on August 19, 2022.